Stimuli-activatable PROTACs for precise protein degradation and cancer therapy
Jing Gao(Qingdao University), Lei Yang(St. Jude Children's Research Hospital), Jian Jin(Icahn School of Medicine at Mount Sinai), Kanyi Pu(Nanyang Technological University), Shumin Lei(Yangzhou University), Tianfeng Xu(Nanjing University of Chinese Medicine), Xiaobao Yang(Beijing Friendship Hospital), Feng Zhou(Soochow University), Chunquan Sheng(Second Military Medical University), Hui‐Jun Nie(Chinese Academy of Sciences), Xiaohua Chen(Fujian Medical University), Bo Peng(China Medical University), Haijun Yu(Alibaba Group (China)), Yu Rao(Soochow University)
Cited by 82
Related Papers
The promise and peril of chemical probes
|Nature Chemical Biology|2015|848
PROTACs: great opportunities for academia and industry
|Signal Transduction and Targeted Therapy|2019|627
Semiconducting Polymer Nanobioconjugates for Targeted Photothermal Activation of Neurons
|Journal of the American Chemical Society|2016|457